Navigation Links
STaK-Chex Plus Retics 5-Part Differential Control

ProductsSTaK-Chex Plus Retics 5-Part Differential Control
Company Streck
Item STaK-Chex Plus Retics 5-Part Differential Control
Features 
Description STaK-Chex Plus Retics is a 5-part differential control that controls all parameters, including reticulocytes, for the Coulter GENS, STKS, LH 750/LH 755, MAXM and HmX instruments. The assay contains automated and manual reticulocyte values for all three levels. White blood cell types and reticulocyte percentages vary and are within clinically significant ranges. This unique product has 14-day open-vial stability and 105-day closed-vial stability, which can be used for three months. The 4.5ml pierceable cap vial is barcoded and compatible with all instruments. Assay disk available.
Info Streck
Customer Service: (800) 228-6090
Web site: http://www.streck.com/default.asp

Related medicine products :

1. STaK-Chex White Cell Differential Control
2. Para 12 Plus Retics 5-Part Differential Control
3. CBC with Platelet Count & Automated Differential
4. Manual Differential
5. Para 5X Whole Blood Hematology Control, Five-part Differential
6. Para 12 Extend Whole Blood Hematology Control, Three-part Differential
7. Para 12 Whole Blood Hematology Control, Three-part Differential
8. Endoalpha Centralized O.R. Control System
9. Cruise Control
10. US Autoflow Single Chamber Stackable Water-Jacketed CO2 Inc.w/ Humidity Display and Control
11. Fluid Control 2203
Breaking Medicine Technology:TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 1New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 2New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 3Pederson Immigration Law Group Attorneys Featured in 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51648 1Pederson Immigration Law Group Attorneys Featured in 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51648 2Pederson Immigration Law Group Attorneys Featured in 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51648 3meridianEMR Completes Surescripts 28R 29 Certification 51645 1meridianEMR Completes Surescripts 28R 29 Certification 51645 2meridianEMR Completes Surescripts 28R 29 Certification 51645 3